NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

But not even I would assert an unambiguous failure. Patients really did live for a long time.

its all about the premises if NWBO has come to the conclusion if FDA approval is feasible, if unlikely the trial has failed.

And yes that is by meeting the bought in (primary) endpoint(s)

If the biotech later on gets FDA dimissed from what it could and should have known than there is hell to pay, Its really no rocket science.